Cargando…
Melanoma-derived Wnt5a conditions dendritic cells to promote regulatory T cell differentiation via the upregulation of indoleamine 2,3-dioxygenase: novel pharmacological strategies for augmenting immunotherapy efficacy
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4292429/ http://dx.doi.org/10.1186/2051-1426-2-S3-P209 |
| _version_ | 1782352483153084416 |
|---|---|
| author | Zhao, Fei Evans, Kathy Holtzhausen, Alisha Orabona, Ciriana Hanks, Brent A |
| author_facet | Zhao, Fei Evans, Kathy Holtzhausen, Alisha Orabona, Ciriana Hanks, Brent A |
| author_sort | Zhao, Fei |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4292429 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-42924292015-01-15 Melanoma-derived Wnt5a conditions dendritic cells to promote regulatory T cell differentiation via the upregulation of indoleamine 2,3-dioxygenase: novel pharmacological strategies for augmenting immunotherapy efficacy Zhao, Fei Evans, Kathy Holtzhausen, Alisha Orabona, Ciriana Hanks, Brent A J Immunother Cancer Poster Presentation BioMed Central 2014-11-06 /pmc/articles/PMC4292429/ http://dx.doi.org/10.1186/2051-1426-2-S3-P209 Text en Copyright © 2014 Zhao et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation Zhao, Fei Evans, Kathy Holtzhausen, Alisha Orabona, Ciriana Hanks, Brent A Melanoma-derived Wnt5a conditions dendritic cells to promote regulatory T cell differentiation via the upregulation of indoleamine 2,3-dioxygenase: novel pharmacological strategies for augmenting immunotherapy efficacy |
| title | Melanoma-derived Wnt5a conditions dendritic cells to promote regulatory T cell differentiation via the upregulation of indoleamine 2,3-dioxygenase: novel pharmacological strategies for augmenting immunotherapy efficacy |
| title_full | Melanoma-derived Wnt5a conditions dendritic cells to promote regulatory T cell differentiation via the upregulation of indoleamine 2,3-dioxygenase: novel pharmacological strategies for augmenting immunotherapy efficacy |
| title_fullStr | Melanoma-derived Wnt5a conditions dendritic cells to promote regulatory T cell differentiation via the upregulation of indoleamine 2,3-dioxygenase: novel pharmacological strategies for augmenting immunotherapy efficacy |
| title_full_unstemmed | Melanoma-derived Wnt5a conditions dendritic cells to promote regulatory T cell differentiation via the upregulation of indoleamine 2,3-dioxygenase: novel pharmacological strategies for augmenting immunotherapy efficacy |
| title_short | Melanoma-derived Wnt5a conditions dendritic cells to promote regulatory T cell differentiation via the upregulation of indoleamine 2,3-dioxygenase: novel pharmacological strategies for augmenting immunotherapy efficacy |
| title_sort | melanoma-derived wnt5a conditions dendritic cells to promote regulatory t cell differentiation via the upregulation of indoleamine 2,3-dioxygenase: novel pharmacological strategies for augmenting immunotherapy efficacy |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4292429/ http://dx.doi.org/10.1186/2051-1426-2-S3-P209 |
| work_keys_str_mv | AT zhaofei melanomaderivedwnt5aconditionsdendriticcellstopromoteregulatorytcelldifferentiationviatheupregulationofindoleamine23dioxygenasenovelpharmacologicalstrategiesforaugmentingimmunotherapyefficacy AT evanskathy melanomaderivedwnt5aconditionsdendriticcellstopromoteregulatorytcelldifferentiationviatheupregulationofindoleamine23dioxygenasenovelpharmacologicalstrategiesforaugmentingimmunotherapyefficacy AT holtzhausenalisha melanomaderivedwnt5aconditionsdendriticcellstopromoteregulatorytcelldifferentiationviatheupregulationofindoleamine23dioxygenasenovelpharmacologicalstrategiesforaugmentingimmunotherapyefficacy AT orabonaciriana melanomaderivedwnt5aconditionsdendriticcellstopromoteregulatorytcelldifferentiationviatheupregulationofindoleamine23dioxygenasenovelpharmacologicalstrategiesforaugmentingimmunotherapyefficacy AT hanksbrenta melanomaderivedwnt5aconditionsdendriticcellstopromoteregulatorytcelldifferentiationviatheupregulationofindoleamine23dioxygenasenovelpharmacologicalstrategiesforaugmentingimmunotherapyefficacy |